FDA Cracks Down on Illegal Tobacco Product Sales
SILVER SPRING, Md., May 20, 2026 The U.S. Food and Drug Administration (FDA) has intensified its enforcement efforts against...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance GCP Gene Therapy Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
.Gov for New Therapy
SILVER SPRING, Md., May 20, 2026 The U.S. Food and Drug Administration (FDA) has intensified its enforcement efforts against...
PRINCETON, N.J. and TOKYO, May 13, 2026 Taiho Oncology and Taiho Pharmaceutical announced that the U.S. Food and Drug...
MUMBAI, India and NAPLES, Fla., May 13, 2026 Global pharmaceutical company Lupin Limited announced that it has received approval...
WASHINGTON, May 11, 2026 The U.S. Food and Drug Administration announced a new initiative aimed at accelerating drug repurposing...
WASHINGTON, D.C., United States – May 8, 2026 The U.S. Food and Drug Administration announced the release of a...
SILVER SPRING, Maryland, May 8, 2026 The U.S. Food and Drug Administration (FDA) has approved Bizengri (zenocutuzumab-zbco) for the...
PRAGUE / BRUSSELS, April 27, 2026 Zentiva has filed an appeal before the Court of Justice of the European...
WASHINGTON, D.C., April 24, 2026 The U.S. Food and Drug Administration has announced a series of accelerated regulatory actions...
WASHINGTON, April 9, 2026 Vanda Pharmaceuticals Inc. has publicly called on the U.S. Food and Drug Administration (FDA) to...
ARLINGTON, Virginia, United States, April 7, 2026 The ALS Association has issued a strong statement warning that the proposed...
